Compare Suven Life Sciences with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES NATCO PHARMA SUVEN LIFE SCIENCES/
NATCO PHARMA
 
P/E (TTM) x -95.5 35.2 - View Chart
P/BV x 1.5 5.0 29.9% View Chart
Dividend Yield % 1.5 0.7 227.4%  

Financials

 SUVEN LIFE SCIENCES   NATCO PHARMA
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
NATCO PHARMA
Mar-19
SUVEN LIFE SCIENCES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs338849 39.8%   
Low Rs169557 30.4%   
Sales per share (Unadj.) Rs52.1573.8 9.1%  
Earnings per share (Unadj.) Rs6.8176.0 3.9%  
Cash flow per share (Unadj.) Rs8.6198.2 4.3%  
Dividends per share (Unadj.) Rs1.506.25 24.0%  
Dividend yield (eoy) %0.60.9 66.5%  
Book value per share (Unadj.) Rs65.3842.7 7.7%  
Shares outstanding (eoy) m127.2836.50 348.7%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.91.2 397.0%   
Avg P/E ratio x37.14.0 929.3%  
P/CF ratio (eoy) x29.63.5 834.1%  
Price / Book Value ratio x3.90.8 465.5%  
Dividend payout %22.03.6 618.4%   
Avg Mkt Cap Rs m32,27225,660 125.8%   
No. of employees `0001.15.0 21.8%   
Total wages/salary Rs m6613,559 18.6%   
Avg. sales/employee Rs Th6,132.24,225.3 145.1%   
Avg. wages/employee Rs Th611.1718.0 85.1%   
Avg. net profit/employee Rs Th803.51,295.9 62.0%   
INCOME DATA
Net Sales Rs m6,63520,945 31.7%  
Other income Rs m2421,302 18.6%   
Total revenues Rs m6,87722,247 30.9%   
Gross profit Rs m1,6047,948 20.2%  
Depreciation Rs m221810 27.3%   
Interest Rs m38193 19.5%   
Profit before tax Rs m1,5878,247 19.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,823 39.4%   
Profit after tax Rs m8696,424 13.5%  
Gross profit margin %24.237.9 63.7%  
Effective tax rate %45.222.1 204.6%   
Net profit margin %13.130.7 42.7%  
BALANCE SHEET DATA
Current assets Rs m6,23223,472 26.6%   
Current liabilities Rs m1,4907,287 20.4%   
Net working cap to sales %71.577.3 92.5%  
Current ratio x4.23.2 129.8%  
Inventory Days Days8692 93.7%  
Debtors Days Days8388 93.6%  
Net fixed assets Rs m4,04318,648 21.7%   
Share capital Rs m127365 34.9%   
"Free" reserves Rs m8,18334,525 23.7%   
Net worth Rs m8,31030,760 27.0%   
Long term debt Rs m180-   
Total assets Rs m10,38943,031 24.1%  
Interest coverage x43.143.7 98.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 131.2%   
Return on assets %8.715.4 56.8%  
Return on equity %10.520.9 50.1%  
Return on capital %19.527.4 71.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,62211,536 48.7%   
Fx outflow Rs m1,7992,939 61.2%   
Net fx Rs m3,8228,597 44.5%   
CASH FLOW
From Operations Rs m3566,688 5.3%  
From Investments Rs m-279-6,122 4.6%  
From Financial Activity Rs m-225-509 44.2%  
Net Cashflow Rs m-14866 -224.5%  

Share Holding

Indian Promoters % 63.4 52.0 121.8%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 0.0 16.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 26.0 140.4%  
Shareholders   37,287 25,395 146.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare SUVEN LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Interglobe Aviation QIP, Rising Premium for Non-Life Insurers, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended lower yesterday. Benchmark indices ended nearly 1% lower, tracking weakness in global markets and dragged primarily by finance and banking stocks.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


May 11, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS